Selected research
Industry Research
Cognition-Enhancing Drugs Industry Research Report 2026
Market perspective
The global Cognition-Enhancing Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cognition-Enhancing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cognition-Enhancing Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cognition-Enhancing Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cognition-Enhancing Drugs include HVMN, Cogstate, Cognition Therapeutics, Biogen Idec and Accelerated Intelligence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cognition-Enhancing Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cognition-Enhancing Drugs Market by Company
HVMN
Cogstate
Cognition Therapeutics
Biogen Idec
Accelerated Intelligence
Cognition-Enhancing Drugs Segment by Type
Oral
Injection
Cognition-Enhancing Drugs Segment by Application
Retail Pharmacies
Drug Stores
Hospital Pharmacies
Cognition-Enhancing Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognition-Enhancing Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cognition-Enhancing Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognition-Enhancing Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cognition-Enhancing Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cognition-Enhancing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Retail Pharmacies
- Drug Stores
- Hospital Pharmacies
Companies covered
- HVMN
- Cogstate
- Cognition Therapeutics
- Biogen Idec
- Accelerated Intelligence
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cognition-Enhancing Drugs Market Size (2021-2032)
- 2.2.2 Global Cognition-Enhancing Drugs Sales (2021-2032)
- 2.2.3 Global Cognition-Enhancing Drugs Market Average Price (2021-2032)
- 2.3 Cognition-Enhancing Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injection
- 2.4 Cognition-Enhancing Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Drug Stores
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cognition-Enhancing Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cognition-Enhancing Drugs Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Cognition-Enhancing Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Cognition-Enhancing Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Cognition-Enhancing Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cognition-Enhancing Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cognition-Enhancing Drugs, Product Type & Application
- 3.8 Global Manufacturers of Cognition-Enhancing Drugs, Established Date
- 3.9 Global Cognition-Enhancing Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 HVMN
- 4.1.1 HVMN Company Information
- 4.1.2 HVMN Business Overview
- 4.1.3 HVMN Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 HVMN Cognition-Enhancing Drugs Product Portfolio
- 4.1.5 HVMN Recent Developments
- 4.2 Cogstate
- 4.2.1 Cogstate Company Information
- 4.2.2 Cogstate Business Overview
- 4.2.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cogstate Cognition-Enhancing Drugs Product Portfolio
- 4.2.5 Cogstate Recent Developments
- 4.3 Cognition Therapeutics
- 4.3.1 Cognition Therapeutics Company Information
- 4.3.2 Cognition Therapeutics Business Overview
- 4.3.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio
- 4.3.5 Cognition Therapeutics Recent Developments
- 4.4 Biogen Idec
- 4.4.1 Biogen Idec Company Information
- 4.4.2 Biogen Idec Business Overview
- 4.4.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biogen Idec Cognition-Enhancing Drugs Product Portfolio
- 4.4.5 Biogen Idec Recent Developments
- 4.5 Accelerated Intelligence
- 4.5.1 Accelerated Intelligence Company Information
- 4.5.2 Accelerated Intelligence Business Overview
- 4.5.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio
- 4.5.5 Accelerated Intelligence Recent Developments
5 Global Cognition-Enhancing Drugs Market Scenario by Region
- 5.1 Global Cognition-Enhancing Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cognition-Enhancing Drugs Sales by Region: 2021-2032
- 5.2.1 Global Cognition-Enhancing Drugs Sales by Region: 2021-2026
- 5.2.2 Global Cognition-Enhancing Drugs Sales by Region: 2027-2032
- 5.3 Global Cognition-Enhancing Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Cognition-Enhancing Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Cognition-Enhancing Drugs Revenue by Region: 2027-2032
- 5.4 North America Cognition-Enhancing Drugs Market Facts & Figures by Country
- 5.4.1 North America Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cognition-Enhancing Drugs Sales by Country (2021-2032)
- 5.4.3 North America Cognition-Enhancing Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cognition-Enhancing Drugs Market Facts & Figures by Country
- 5.5.1 Europe Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cognition-Enhancing Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Cognition-Enhancing Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cognition-Enhancing Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cognition-Enhancing Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cognition-Enhancing Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cognition-Enhancing Drugs Market Facts & Figures by Country
- 5.7.1 South America Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cognition-Enhancing Drugs Sales by Country (2021-2032)
- 5.7.3 South America Cognition-Enhancing Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cognition-Enhancing Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cognition-Enhancing Drugs Sales by Type (2021-2032)
- 6.1.1 Global Cognition-Enhancing Drugs Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Cognition-Enhancing Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Cognition-Enhancing Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Cognition-Enhancing Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Cognition-Enhancing Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cognition-Enhancing Drugs Sales by Application (2021-2032)
- 7.1.1 Global Cognition-Enhancing Drugs Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Cognition-Enhancing Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Cognition-Enhancing Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Cognition-Enhancing Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Cognition-Enhancing Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cognition-Enhancing Drugs Value Chain Analysis
- 8.1.1 Cognition-Enhancing Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cognition-Enhancing Drugs Production Mode & Process
- 8.2 Cognition-Enhancing Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cognition-Enhancing Drugs Distributors
- 8.2.3 Cognition-Enhancing Drugs Customers
9 Global Cognition-Enhancing Drugs Analyzing Market Dynamics
- 9.1 Cognition-Enhancing Drugs Industry Trends
- 9.2 Cognition-Enhancing Drugs Industry Drivers
- 9.3 Cognition-Enhancing Drugs Industry Opportunities and Challenges
- 9.4 Cognition-Enhancing Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst